The utility of hyperthermia for local recurrence of breast cancer

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Yamamoto, Daigo ^a,c   Inui, Toshio ^b   Tsubota, Yu ^a   Sueoka, Noriko ^a   Yamamoto, Chizuko ^c   Kuwana, Kayoko ^a   Yamamoto, Mitsuo ^c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Iuni Clinic   (Japan)

^c Seiko Hospital   (Japan)

Author keywords

Breast cancer; Hyperthermia; Skin metastasis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; PROGESTERONE RECEPTOR;

AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; LYMPH NODE DISSECTION; MASTECTOMY; OUTCOME ASSESSMENT; RADIATION DOSE; TREATMENT DURATION;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 84866693737     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-201     Document Type: Article

References (21)

1. Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro. Int J Radiat Biol Relat Stud Phys Chem Med 1971, 19:467-477. 10.1080/09553007114550601, 5314347.
2. Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 2001, 77:399-408. 10.1080/09553000010024687, 11304434.
3. Raaphorst GP, Ng CE, Yang DP. Thermal radiosensitization and repair inhibition in human melanoma cells: a comparison of survival and DNA double strand breaks. Int J Hyperthermia 1999, 15:17-27. 10.1080/026567399285828, 10193754.
4. Dewhirst MW. Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol 1998, 8:143-150. 10.1016/S1053-4296(98)80040-4, 9634491.
5. Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, Prosnitz LR, Jones EL. Hyperthermia for locally advanced breast cancer. Int J Hyperthermia 2010, 26:618-624. 10.3109/02656736.2010.501051, 2949291, 20849257.
6. Uto Y, Hori H, Kubo K, Ichihashi M, Sakamoto N, Mette M, Inui T. GcMAF: our next generation immunotherapy. Nature 2012, 485:S67-S70.
7. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005, 23:3079-3085. 10.1200/JCO.2005.05.520, 15860867.
8. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WLJ, van Rhoon GC, van Dijk JDP, Gonzalez Gonzalez D. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996, 35:731-744. 10.1016/0360-3016(96)00154-X, 8690639.
9. Lee HK, Antell AG, Perez CA, Straube WL, Ramachandran G, Myerson RJ, Emami B, Molmenti EP, Buckner A, Lockett MA. Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors. Int J Radiat Oncol Biol Phys 1998, 40:365-375. 10.1016/S0360-3016(97)00740-2, 9457823.
10. Hehr T, Lamprecht U, Glocker S, Classen J, Paulsen F, Budach W, Bamberg M. Thermoradiotherapy for locally recurrent breast cancer with skin involvement. Int J Hyperthermia 2001, 17:291-301.
11. Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 2001, 6:316-325. 10.1379/1466-1268(2001)006<0316:EOIHET>2.0.CO;2, 434414, 11795468.
12. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery. Effect of particle size. Cancer Res 2000, 60:4440-4445.
13. Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of technetium-99 m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000, 6:3748-3755.
14. Griffin RJ, Okajima K, Barrios B, Song CW. Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radio-sensitivity. Cancer Res 1996, 56:5590-5593.
15. Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996, 12:367-373. 10.3109/02656739609022525, 9044906.
16. Vujaskovic Z, Poulson JM, Gaskin AA, Thrall DE, Page RL, Charles HC, MacFall JR, Brizel DM, Meyer RE, Prescott DM. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys 2000, 46:179-185. 10.1016/S0360-3016(99)00362-4, 10656391.
17. Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia 2006, 22:365-373. 10.1080/02656730600836386, 16891239.
18. Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, Craciunescu O, Stauffer P, Liotcheva V, Betof A, Blackwell K. A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. Int J Hyperthermia 2010, 26:514-521. 10.3109/02656731003639364, 2956498, 20377362.
19. Craciunescu OI, Thrall DE, Vujaskovic Z, Dewhirst MW. Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer. Int J Hyperthermia 2010, 26:625-637. 10.3109/02656736.2010.499526, 2998919, 20849258.
20. Iwase S, Yamamoto D, Kuroda Y, Kawaguchi T, Kitamura K, Odagiri H, Teramoto S, Akazawa K, Nagumo Y. Phase II trial of preoperative chemotherapy for breast cancer: Japan Breast Cancer Research Network (JBCRN)-02 trial. Anticancer Res 2011, 31:1483-1487.
21. Yamamoto D, Iwase S, Yoshida H, Kuroda Y, Yamamoto C, Kitamura K, Odagiri H, Nagumo Y. Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 trial. Anticancer Res 2011, 31:3567-3571.